Go to content
UR Home

Effects of Alemtuzumab on (Auto) antigen-Specific Immune Responses

URN to cite this document:
DOI to cite this document:
Weissert, Robert ; Hilger, Clara ; Riedhammer, Christine ; Orsó, Evelyn
License: Creative Commons Attribution 4.0
PDF - Published Version
Date of publication of this fulltext: 02 Nov 2020 12:00


Alemtuzumab (anti-CD52 mAb) leads to a long-lasting disease activity suppression in patients with relapsing forms of multiple sclerosis (MS). In this study, we examined the change of the immune cell repertoire and the cellular reactivity after treatment with alemtuzumab. We analyzed the number of IFN-gamma-secreting cells in presence of several peptides which had been eluted from the central ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons